Christopher W. Lee
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
Papers in
-
- Occupational and environmental lung diseases 7
- Lung Cancer Treatments and Mutations 6
- Pleural and Pulmonary Diseases 5
- Lung Cancer Diagnosis and Treatment 5
- Oncology 11
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
- Co-authors
- Kim N. (1 shared paper)Lesley Seymour (8 shared papers)Keyue Ding (5 shared papers)Frances A. Shepherd (5 shared papers)Glenwood Goss (6 shared papers)Nevin Murray (7 shared papers)Andrew Arnold (3 shared papers)Kerry J. Savage (4 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Journal of Thoracic Oncology (4 papers)Investigational New Drugs (1 paper)General and Comparative Endocrinology (1 paper)Lung Cancer (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Christopher W. Lee
23 papers receiving 965 citations
Peers
Comparison fields: 5 of 81
- Oncology 410
- Pulmonary and Respiratory Medicine 352
- Genetics 64
- Cancer Research 61
- Cell Biology 67
Countries citing papers authored by Christopher W. Lee
This map shows the geographic impact of Christopher W. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Lee more than expected).
Fields of papers citing papers by Christopher W. Lee
This network shows the impact of papers produced by Christopher W. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Lee. The network helps show where Christopher W. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher W. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 187 | |
| 2 | 2007 | 156 | |
| 3 | 2007 | 83 | |
| 4 | 2000 | 74 | |
| 5 | 2017 | 70 | |
| 6 | 2015 | 65 | |
| 7 | 2008 | 59 | |
| 8 | 2011 | 52 | |
| 9 | 2010 | 47 | |
| 10 | 2008 | 45 | |
| 11 | 2013 | 30 | |
| 12 | 2016 | 29 | |
| 13 | 2023 | 20 | |
| 14 | 2020 | 20 | |
| 15 | 2013 | 13 | |
| 16 | 2018 | 9 | |
| 17 | 2012 | 8 | |
| 18 | 2007 | 5 | |
| 19 | 2016 | 5 | |
| 20 | 2014 | 3 |
About Christopher W. Lee
Christopher W. Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Biotechnology and Molecular Biology, having authored 23 papers that have together received 985 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (7 papers), Lung Cancer Treatments and Mutations (6 papers), Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (410 citations), Pulmonary and Respiratory Medicine (352 citations), Genetics (64 citations), Cancer Research (61 citations) and Cell Biology (67 citations). Christopher W. Lee has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Kim N., Lesley Seymour, Keyue Ding, Frances A. Shepherd, Glenwood Goss, Nevin Murray, Andrew Arnold, Kerry J. Savage, Sanjay C. Rao and Helén Anderson. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Investigational New Drugs, General and Comparative Endocrinology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.